跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gixime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gixime
Approved
STANDARD
Gixime
Scott-Edil Advance Research Laboratories & Education Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
932091a766a7d74a
Company
Scott-Edil Advance Research Laboratories & Education Limited
Type
Standard
Approval Details
Approval Id
932091a766a7d74a
Drug Approval Philippines Name
Gixime
Product Name
Gixime
Registration Number
DRP-4976-16
Brand Name
Gixime
Generic Name
Cefuroxime (as sodium)
Dosage Form
Powder For Injection
Dosage Strength
750 mg
Manufacturer
Scott-Edil Advance Research Laboratories & Education Limited
Importer
Pharmakon Biotec Inc.
Distributor
Gijun Trading
Issuance Date
29 December 2023
Expiry Date
27 November 2028
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
932091a766a7d74a
Type
Standard
Back to Philippines FDA Approvals